ArticleExperimental & molecular medicine2020

Quantitative phosphoproteomic analysis identifies the potential therapeutic target EphA2 for overcoming sorafenib resistance in hepatocellular carcinoma cells.

Chih-Ta Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.